JOHNSON & JOHNSON Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2009 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Johnson & Johnson quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2009 to Q3 2024.
  • Johnson & Johnson Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 29, 2024 was $16.2B, a 9.3% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $16.2B +$1.38B +9.3% Sep 29, 2024 10-Q 2024-10-23
Q2 2024 $15.8B -$983M -5.86% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $14.9B -$1.4B -8.59% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $14.9B +$834M +5.94% Dec 31, 2023 10-Q 2024-10-23
Q3 2023 $14.8B -$1.09B -6.87% Oct 1, 2023 10-Q 2023-10-27
Q2 2023 $16.8B +$638M +3.95% Jul 2, 2023 10-Q 2023-07-31
Q1 2023 $16.4B +$756M +4.85% Apr 2, 2023 10-Q 2023-04-28
Q4 2022 $14B -$1.24B -8.14% Jan 1, 2023 10-K 2024-02-16
Q3 2022 $15.9B +$979M +6.57% Oct 2, 2022 10-Q 2022-10-27
Q2 2022 $16.1B +$1.27B +8.53% Jul 3, 2022 10-Q 2022-07-29
Q1 2022 $15.6B +$656M +4.39% Apr 3, 2022 10-Q 2022-04-29
Q4 2021 $15.3B +$1.71B +12.6% Jan 2, 2022 10-K 2023-02-16
Q3 2021 $14.9B +$332M +2.28% Oct 3, 2021 10-Q 2021-10-29
Q2 2021 $14.9B +$226M +1.54% Jul 4, 2021 10-Q 2021-07-29
Q1 2021 $14.9B +$64M +0.43% Apr 4, 2021 10-Q 2021-04-30
Q4 2020 $13.6B -$905M -6.25% Jan 3, 2021 10-K 2022-02-17
Q3 2020 $14.6B -$222M -1.5% Sep 27, 2020 10-Q 2020-10-23
Q2 2020 $14.6B -$8M -0.06% Jun 28, 2020 10-Q 2020-07-24
Q1 2020 $14.9B +$759M +5.38% Mar 29, 2020 10-Q 2020-04-29
Q4 2019 $14.5B +$383M +2.72% Dec 29, 2019 10-K 2021-02-22
Q3 2019 $14.8B +$753M +5.36% Sep 29, 2019 10-Q 2019-10-28
Q2 2019 $14.7B +$542M +3.84% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $14.1B -$51M -0.36% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $14.1B +$608M +4.51% Dec 30, 2018 10-K 2020-02-18
Q3 2018 $14B +$893M +6.79% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $14.1B +$828M +6.23% Jul 1, 2018 10-Q 2018-08-02
Q1 2018 $14.2B +$1.87B +15.2% Apr 1, 2018 10-Q 2018-05-01
Q4 2017 $13.5B +$1.79B +15.3% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $13.2B +$1.36B +11.5% Oct 1, 2017 10-Q 2017-11-02
Q2 2017 $13.3B +$1.22B +10.1% Jul 2, 2017 10-Q 2017-08-03
Q1 2017 $12.3B +$894M +7.84% Apr 2, 2017 10-Q 2017-05-08
Q4 2016 $11.7B +$965M +8.99% Jan 1, 2017 10-K 2018-02-21
Q3 2016 $11.8B +$432M +3.8% Oct 2, 2016 10-Q 2016-11-04
Q2 2016 $12.1B +$94M +0.79% Jul 3, 2016 10-Q 2016-08-04
Q1 2016 $11.4B -$127M -1.1% Apr 3, 2016 10-Q 2016-05-10
Q4 2015 $10.7B -$251M -2.29% Jan 3, 2016 10-K 2017-02-27
Q3 2015 $11.4B -$249M -2.14% Sep 27, 2015 10-Q 2015-10-30
Q2 2015 $12B -$289M -2.36% Jun 28, 2015 10-Q 2015-07-31
Q1 2015 $11.5B -$583M -4.81% Mar 29, 2015 10-Q 2015-05-01
Q4 2014 $11B -$728M -6.22% Dec 28, 2014 10-K 2016-02-24
Q3 2014 $11.6B -$412M -3.43% Sep 28, 2014 10-Q 2014-10-30
Q2 2014 $12.3B +$643M +5.54% Jun 29, 2014 10-Q 2014-08-01
Q1 2014 $12.1B +$601M +5.22% Mar 30, 2014 10-Q 2014-05-02
Q4 2013 $11.7B +$404M +3.57% Dec 29, 2013 10-K 2015-02-24
Q3 2013 $12B +$852M +7.62% Sep 29, 2013 10-Q 2013-11-04
Q2 2013 $11.6B +$622M +5.66% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $11.5B +$533M +4.85% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $11.3B +$728M +6.88% Dec 30, 2012 10-K 2014-02-21
Q3 2012 $11.2B +$623M +5.9% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $11B +$10M +0.09% Jul 1, 2012 10-Q 2012-08-02
Q1 2012 $11B +$121M +1.11% Apr 1, 2012 10-Q 2012-05-07
Q4 2011 $10.6B +$807M +8.26% Jan 1, 2012 10-K 2013-02-22
Q3 2011 $10.6B +$262M +2.55% Oct 2, 2011 10-Q 2011-11-08
Q2 2011 $11B +$1.35B +14.1% Jul 3, 2011 10-Q 2011-08-09
Q1 2011 $10.9B +$843M +8.42% Apr 3, 2011 10-Q 2011-05-10
Q4 2010 $9.77B +$128M +1.33% Jan 2, 2011 10-K 2012-02-23
Q3 2010 $10.3B Oct 3, 2010 10-Q 2010-11-10
Q2 2010 $9.63B Jul 4, 2010 10-Q 2010-08-11
Q1 2010 $10B Apr 4, 2010 10-Q 2010-05-10
Q4 2009 $9.65B Jan 3, 2010 10-K 2011-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.